Texas representatives grilled the CEO of Superior HealthPlan, Mark Sanders, for emails allegedly showing he had hired private investigators to watch state representatives, a journalist and private citizens seeking health care coverage.

CVS has been hit with at least three federal class actions, including two antitrust cases accusing CVS Caremark Corp. and other pharmacy benefit managers, the intermediaries between insurance companies and pharmacies, of price-fixing prescription drug reimbursement rates.

In addition, the companies agreed to internal reforms to uphold competition in the industry and follow antitrust laws.

Class action lawsuits alleging violations of the Employee Retirement Income Security Act of 1974 are on the rise nationally against companies allegedly charging a higher premium for policyholders who use tobacco.

DoctorNow alleged that the defendants were required to provide full coverage and reimbursement for COVID-19 testing.

"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.

Boehringer Ingelheim, one of 10 companies sent a warning letter by the FTC disputing the accuracy of patent listings in the FDA's Orange Book, was hit with an class action lawsuit, alleging that the company is using expired patents.

The health fund for the International Union of Operating Engineers is suing Eli Lilly, Novo Nordisk and Sanofi, as well as CVS Health and other PBMs, for "drastically" increasing the price of life-saving meds for "illicit profits."